In GL261 glioma cell line from C57BL/6 mice, it has been demonstrated that VEGF is a modulator of the innate immune response instigating suppressive effects acting on the immunologic and pro-angiogenic function of microglia/macrophages. This evidence concerns the gene VEGFA and central nervous system cancer.